| Literature DB >> 36034933 |
Machoene Derrick Sekgala1,2, Maretha Opperman3, Buhle Mpahleni3, Zandile June-Rose Mchiza1,4.
Abstract
Background: Detecting the early onset of metabolic syndrome (MetS) allows for quick intervention which may slow progression to a variety of health consequences, hence, determining the best measurement to detect MetS is essential. Aim: This research aimed at examining the MetS predictive power of anthropometric indices, such as body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), body shape index (ABSI), body roundness index (BRI), percentage body fat (%BF), conicity index (CI), and Clínica Universidad de Navarra-body adiposity estimator (CUN-BAE) to determine the cut-off points to identify male South African taxi drivers with MetS. Method: A cross-sectional study was conducted among 185 male taxi drivers. Their weight, height, WC, blood lipid profile were measured. International Diabetes Federation (IDF) definition was used to define MetS. Receiver Operating Characteristic (ROC) curves were used to compare the predictive ability of Anthropometric indices to detect MetS.Entities:
Keywords: a body shape index (ABSI); anthropometric indices; body mass index (BMI); body roundness index (BRI); metabolic syndrome; receiver operating characteristic curve; waist circumference; waist-to-height ratio (WHtR)
Year: 2022 PMID: 36034933 PMCID: PMC9406286 DOI: 10.3389/fnut.2022.974749
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Flow diagram of participants' selection for this study.
Sociodemographic and anthropometric characteristics by the presence/absence of MetS among the taxi drivers in Western Cape, South Africa.
|
|
|
|
| |
|---|---|---|---|---|
| Age (years) | 39.84 ± 10.46 | 43.73 ± 10.34 | 37.27 ± 10.21 | <0.001 |
| Race | 0.932 | |||
| Merital status | 0.279 | |||
| Driving experience (years) | <0.001 | |||
| Educational level | 0.714 | |||
| BMI (kg/m2) | 28.60 ± 6.20 | 32.71 ± 5.88 | 25.65 ± 5.21 | <0.001 |
| WC (cm) | 99.13 ± 17.59 | 110.83 ± 16.72 | 90.72 ± 14.50 | <0.001 |
| WHtR | 0.58 ± 0.10 | 0.64 ± 0.09 | 0.53 ± 0.09 | <0.001 |
| Weight (kg) | 84.74 ± 19.67 | 97.35 ± 18.66 | 75.52 ± 16.41 | <0.001 |
| Height (cm) | 172.03 ± 7.93 | 172.59 ± 9.33 | 171.44 ± 7.23 | 0.387 |
| %BF | 27.28 ± 8.28 | 33.11 ± 7.63 | 23.16 ± 6.85 | <0.001 |
| ABSI | 0.0812 ± 0.0840 | 0.0829 ± 0.0901 | 0.0800 ± 0.00775 | <0.001 |
| BRI | 5.09 ± 2.33 | 6.68 ± 2.50 | 4.06 ± 1.81 | <0.001 |
| CUN-BAE | 27.78 ± 8.34 | 33.55 ± 6.61 | 23.53 ± 7.52 | <0.001 |
| CI | 1.70 ± 0.19 | 1.78 ± 0.21 | 1.65 ± 0.17 | <0.001 |
| Biceps | 10.66 ± 6.73 | 12.84 ± 6.06 | 8.53 ± 3.31 | <0.001 |
| Triceps | 17.41 ± 8.75 | 20.56 ± 9.53 | 14.95 ± 7.40 | <0.001 |
| Subscapular | 26.16 ± 13.58 | 32.14 ± 13.76 | 21.21 ± 10.87 | <0.001 |
| Suprailiac | 24.20 ± 13.08 | 29.40 ± 11.07 | 19.40 ± 10.90 | <0.001 |
BMI, Body Mass index; WC, Waist circumference; WHtR, waist-to-height Ratio; %B, percentage body fat; ABSI, a body shape index; BRI, body roundness index; CUN-BAE, Clínica Universidad de Navarra-Body Adiposity Estimator; CI, Conicity index; MetS, metabolic syndrome. The numerical values are presented as mean ± standard deviation and intergroup compared using the Mann-Whitney U test.
Mean non-communicable disease risk factors by the presence/absence of MetS.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
| ||
| Triglycerides (mmol/L) | 1.35 ± 1.12 | 1.88 ± 1.49 | 0.96 ± 0.45 | <0.001 |
| HDL-c (mmol/L) | 1.11 ± 0.34 | 1.00 ± 0.28 | 1.20 ± 0.36 | <0.001 |
| FBG (mmol/L) | 6.50 ± 3.44 | 7.87 ± 4.82 | 5.33 ± 1.13 | <0.001 |
| SBP (mmHg) | 133.44 ± 17.17 | 141.47 ± 18.79 | 127.40 ± 13.33 | <0.001 |
| DBP (mmHg) | 84.71 ± 13.08 | 92.73 ± 13.94 | 79.07 ± 9.12 | <0.001 |
| WC (cm) | 99.13 ± 17.59 | 110.83 ± 16.72 | 90.72 ± 14.50 | <0.001 |
HDL-c, high-density lipoprotein cholesterol; FBG, fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; WC, waist circumference; MetS, metabolic syndrome. Values are reported as the mean ± standard deviation.
Risk factors of MetS grouped by the presence and absence of MetS.
|
|
|
| |||
|---|---|---|---|---|---|
|
|
|
|
| ||
| Triglycerides (mmol/L) | |||||
| HDL-c (mmol/L) | |||||
| FBG (mmol/L) | |||||
| SBP (mmHg) | |||||
| DBP (mmHg) | |||||
| Hypertension | |||||
| WC (cm) |
HDL-c, high-density lipoprotein cholesterol; FBG, fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; WC, waist circumference; MetS, metabolic syndrome. Values are reported as the mean ± standard deviation.
Area under the curves (AUC) and cut-off points for the anthropometric indices for the prediction of MetS and its risk factors.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| BMI (kg/m2) | MetS (IDF criterion) | 83.8% | 0.782–0.895 | <0.001 | 28.25 | 80.5% | 25.0% |
| WHtR | 83.2% | 0.775–0.889 | <0.001 | 0.55 | 87.0% | 36.1% | |
| %BF | 84.8% | 0.794–0.902 | <0.001 | 25.29 | 85.7% | 29.6% | |
| ABSI | 67.7% | 0.599–0.756 | <0.001 | 0.08 | 70.1% | 38.9% | |
| BRI | 83.2% | 0.775–0.889 | <0.001 | 4.55 | 80.5% | 36.1% | |
| CUN-BAE | 84.6% | 0.791–0.901 | <0.001 | 27.10 | 84.4% | 27.8% | |
| CI | 76.2% | 0.694–0.831 | <0.001 | 1.70 | 74.0% | 36.1% | |
| BMI (kg/m2) | Triglycerides (mmol/L) | 67.8% | 0.588–0.768 | 0.001 | 28.69 | 63.2% | 39.5% |
| WHtR | 69.3% | 0.606–0.780 | <0.001 | 0.57 | 71.1% | 44.2% | |
| %BF | 60.5% | 0.577–0.761 | 0.001 | 25.57 | 71.1% | 46.2% | |
| ABSI | 69.3% | 0.506–0.705 | 0.046 | 0.08 | 60.5% | 40.8% | |
| BRI | 69.3% | 0.606–0.780 | <0.001 | 5.25 | 60.5% | 34.0% | |
| CUN-BAE | 67.6% | 0.586–0.767 | 0.001 | 29.19 | 60.5% | 36.7% | |
| CI | 63.4% | 0.535–0.732 | 0.011 | 1.71 | 60.5% | 38.8% | |
| BMI (kg/m2) | HDL-C (mmol/L) | 70.9% | 0.634–0.784 | <0.001 | 27.74 | 70.5% | 34.4% |
| WHtR | 65.0% | 0.582–0.738 | <0.001 | 0.57 | 60.0% | 37.8% | |
| %BF | 69.0% | 0.614–0.766 | <0.001 | 25.35 | 67.4% | 36.7% | |
| ABSI | 53.7% | 0.453–0.621 | 0.384 | 0.081 | 50.5% | 43.3% | |
| BRI | 66.0% | 0.582–0.738 | <0.001 | 4.77 | 60.0% | 37.8% | |
| CUN-BAE | 70.2% | 0.627–0.777 | <0.001 | 26.85 | 70.5% | 35.6% | |
| CI | 60.3% | 0.521–0.685 | 0.015 | 1.71 | 60.0% | 36.7% | |
| BMI (kg/m2) | Fasting glucose (mmol/L) | 62.5% | 0.544–0.706 | 0.003 | 27.74 | 60.9% | 46.2% |
| WHtR | 61.3% | 0.532–0.694 | 0.008 | 0.57 | 57.6% | 44.1% | |
| %BF | 64.5% | 0.566–0.725 | 0.001 | 25.68 | 60.9% | 40.9% | |
| ABSI | 55.3% | 0.470–0.636 | 0.214 | 0.081 | 52.2% | 45.2% | |
| BRI | 61.3% | 0.532–0.694 | 0.008 | 4.88 | 54.3% | 39.8% | |
| CUN-BAE | 63.5% | 0.555–0.716 | 0.001 | 27.25 | 60.9% | 40.9% | |
| CI | 57.3% | 0.491–0.656 | 0.085 | 1.72 | 42.4% | 37.6% | |
| BMI (kg/m2) | BP (mmHg) | 64.0% | 0.558–0.722 | 0.002 | 27.44 | 64.6% | 49.2% |
| WHtR | 63.3% | 0.551–0.716 | 0.003 | 0.58 | 60.0% | 36.7% | |
| %BF | 66.0% | 0.578–0.741 | <0.001 | 26.23 | 64.6% | 39.2% | |
| ABSI | 59.6% | 0.511–0.682 | 0.031 | 0.08 | 61.5% | 39.2% | |
| BRI | 63.4% | 0.551–0.716 | 0.003 | 4.92 | 60.0% | 36.7% | |
| CUN-BAE | 64.8% | 0.565–0.731 | 0.001 | 28.31 | 60.0% | 37.5% | |
| CI | 63.4% | 0.550–0.719 | 0.003 | 1.70 | 60.0% | 43.3% | |
| BMI (kg/m2) | WC (cm) | 91.8% | 0.876–0.961 | <0.001 | 25.52 | 91.8% | 25.3% |
| WHtR | 96.2% | 0.933–0.991 | <0.001 | 0.52 | 99.1% | 29.3% | |
| %BF | 92.9% | 0.887–0.970 | <0.001 | 23.84 | 92.7% | 17.3% | |
| ABSI | 78.3% | 0.714–0.852 | <0.001 | 0.08 | 77.3% | 29.3% | |
| BRI | 96.2% | 0.933–0.991 | <0.001 | 4.14 | 94.5% | 12.0% | |
| CUN-BAE | 92.8% | 0.887–0.970 | <0.001 | 25.12 | 92.7% | 16.0% | |
| CI | 93.5% | 0.899–0.971 | <0.001 | 1.66 | 90.9% | 14.7% |
BMI, Body Mass index; WC, Waist circumference; WHtR, waist-to-height Ratio; %B, percentage body fat; ABSI, a body shape index; BRI, body roundness index; CUN-BAE, Clínica Universidad de Navarra-Body Adiposity Estimator; CI, Conicity index; MetS, metabolic syndrome; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; WC, waist circumference.
Figure 2(A) ROC curve of the anthropometric indices for the prediction of MetS. (B) ROC curve of the anthropometric indices for the prediction of triglyceride. (C) ROC curve of the anthropometric indices for the prediction of HDL-C. (D) ROC curve of the anthropometric indices for the prediction of FBG. (E) ROC curve of the anthropometric indices for the prediction of Hypertension. (F) ROC curve of the anthropometric indices for the prediction of WC. (A–F) shows the ROC curve of the anthropometric indices cut off points for the prediction of MetS and its components.
Optimal cut-off point for components of MetS.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Triglycerides (mmol/L) | 76.7% | 0.697–0.837 | <0.000 | 1.11 | 70.1% | 29.6% |
| HDL-c (mmol/L) | 71.2% | 0.635–0.789 | <0.000 | 1.03 | 70.4% | 32.5% |
| Fasting blood glucose (mmol/L) | 77.0% | 0.703–0.838 | <0.000 | 5.35 | 79.2% | 37.0% |
| SBP (mmHg) | 72.5% | 0.650–0.800 | <0.000 | 130.50 | 70.1% | 44.4% |
| DBP (mmHg) | 80.5% | 0.739–0.870 | <0.000 | 85.5 | 70.1% | 23.1% |
| Waist circumference (cm) | 83.6% | 0.780–0.837 | <0.000 | 99.00 | 81.8% | 29.6% |
SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high density lipo-protein- cholesterol.
The risk for metabolic syndrome among South African males aged 20 years and older by anthropometric indices.
|
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| ||
| BMI (kg/m2) | 1.277 | 1.182–1.379 | <0.001 | 1.261 | 1.166–1.363 | <0.001 | 1.271 | 1.170–1.382 | <0.001 | 1.269 | 1.165–1.382 | <0.001 |
| WHtR (cat) | 0.023 | 0.003–0.174 | <0.001 | 0.026 | 0.003–0.196 | <0.001 | 0.028 | 0.004–0.215 | 0.001 | 0.030 | 0.004–0.232 | 0.001 |
| %BF | 1.214 | 1.145–1.288 | <0.001 | 1.213 | 1.137–1.294 | <0.001 | 1.221 | 1.140–1.308 | <0.001 | 1.220 | 1.136–1.309 | <0.001 |
| ABSI (cat) | 2.853 | 0.254–32.041 | 0.395 | 1.663 | 0.145–19.041 | 0.683 | 2.228 | 0.170–29.270 | 0.540 | 1.754 | 0.123–25.036 | 0.679 |
| BRI | 1.922 | 1.549–2.386 | <0.001 | 1.817 | 1.466–2.250 | <0.001 | 1.860 | 1.478–2.342 | <0.001 | 1.819 | 1.442–2.294 | <0.001 |
| CUN-BAE | 1.215 | 1.146–1.288 | <0.001 | 1.202 | 1.132–1.276 | <0.001 | 1.210 | 1.136–1.289 | <0.001 | 1.210 | 1.134–1.292 | <0.001 |
| CI cat | 2.853 | 0.254–32.041 | 0.395 | 1.663 | 0.145–19.041 | 0.683 | 2.228 | 0.170–29.270 | 0.540 | 1.754 | 0.123–25.036 | 0.679 |
|
| ||||||||||||
| Triglycerides (mmol/L) | 5.468 | 2.879–10.387 | <0.001 | 5.883 | 2.957–11.703 | <0.001 | 6.205 | 2.986–12.892 | <0.001 | 7.370 | 3.337–16.279 | <0.001 |
| HDL-c (mmol/L) | 0.089 | 0.026–0.308 | <0.001 | 0.085 | 0.023–0.320 | <0.001 | 0.079 | 0.020–0.308 | <0.001 | 0.067 | 0.016–0.288 | <0.001 |
| FBG (mmol/L) | 1.869 | 1.402–2.492 | <0.001 | 1.765 | 1.317–2.366 | <0.001 | 1.693 | 1.254–2.286 | 0.001 | 1.770 | 1.295–2.419 | 0.001 |
| SBP (mmHg) | 1.063 | 1.037–1.089 | <0.001 | 1.064 | 1.037–1.092 | <0.001 | 1.070 | 1.041–1.101 | <0.001 | 1.067 | 1.037–1.098 | <0.001 |
| DBP (mmHg) | 1.121 | 1.080–1.163 | <0.001 | 1.117 | 1.075–1.161 | <0.001 | 1.121 | 1.077–1.167 | <0.001 | 1.119 | 1.073–1.168 | <0.001 |
| Hypertension (cat) | 0.099 | 0.049–0.201 | <0.001 | 0.108 | 0.052–0.223 | <0.001 | 0.092 | 0.042–0.203 | <0.001 | −0.102 | 0.046–0.226 | <0.001 |
| WC (cm) | 1.097 | 1.065–1.129 | <0.001 | 1.090 | 1.059–1.122 | <0.001 | 1.092 | 1.059–1.126 | <0.001 | 1.090 | 1.056–1.124 | <0.001 |
Three logistic regression models were applied: model 1, adjusted for age; model 2, adjusted for age, race, marital status, driving experience in years, and education; and model 3, further adjusted for age, race, marital status, driving experience in years, education, smoking, alcohol and physical activity. BMI, Body Mass index; WC, Waist circumference; WHtR, waist-to-height Ratio; %BF, percentage body fat; ABSI, a body shape index; BRI, body roundness index; CUN-BAE, Clínica Universidad de Navarra-Body Adiposity Estimator; CI, Conicity index; MetS, metabolic syndrome; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; WC, waist circumference. Cat: categorical variable, Hypertension: systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg, WHtR: (> 0.5), CI: (>1.25), ABSI: > 0.086.
The unadjusted and adjusted odds ratios (ORs) of the combination BMI and BRI, BMI and WHtR, and BRI and WHtR for prediction of MetS and its risk factors.
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
| |
| MetS | 1.211 | 1.141–1.286 | <0.001 | 1.274 | 1.180–1.375 | <0.001 | 1.871 | 1.522–2.302 | <0.001 |
| Triglycerides | 1.072 | 1.029–1.117 | <0.001 | 1.095 | 1.038–1.156 | <0.001 | 1.222 | 1.069–1.397 | 0.003 |
| HDL-c | 1.088 | 1.045–1.133 | <0.001 | 1.121 | 1.062–1.182 | <0.001 | 1.256 | 1.097–1.439 | <0.001 |
| FBG | 1.051 | 1.015–1.087 | 0.005 | 1.065 | 1.019–1.114 | 0.005 | 1.173 | 1.041–1.321 | 0.009 |
| Hypertension | 1.056 | 1.021–1.093 | 0.002 | 1.073 | 1.026–1.123 | 0.002 | 1.184 | 1.053–1.332 | 0.005 |
| WC | 1.564 | 1.388–1.761 | <0.001 | 1.601 | 1.419–1.806 | <0.001 | 9.955 | 5.234–19.010 | <0.001 |
|
| |||||||||
| MetS | 1.197 | 1.128–1.277 | <0.001 | 1.258 | 1.165–1.358 | <0.001 | 1.773 | 1.444–2.177 | <0.001 |
| Triglycerides | 1.072 | 1.028–1.118 | 0.001 | 1.094 | 1.036–1.156 | 0.001 | 1.219 | 1.063–1.397 | 0.005 |
| HDL-c | 1.092 | 1.047–1.138 | <0.001 | 1.125 | 1.064–1.187 | <0.001 | 1.267 | 1.101–1.458 | <0.001 |
| FBG | 1.039 | 1.004–1.076 | 0.030 | 1.051 | 1.005–1.100 | 0.030 | 1.124 | 0.995–1.269 | 0.060 |
| Hypertension | 1.048 | 1.012–1.086 | 0.009 | 1.063 | 1.016–1.113 | 0.008 | 1.150 | 1.020–1.297 | 0.023 |
| WC | 1.584 | 1.396–1.797 | <0.001 | 1.629 | 1.429–1.857 | <0.001 | 9.783 | 5.091–18.800 | <0.001 |
|
| |||||||||
| MetS | 1.203 | 1.130–1.280 | <0.001 | 1.264 | 1.167–1.370 | <0.001 | 1.777 | 1.436–2.199 | <0.001 |
| Triglycerides | 1.072 | 1.027–1.120 | 0.002 | 1.094 | 1.034–1.158 | 0.002 | 1.225 | 1.065–1.408 | 0.004 |
| HDL-c | 1.094 | 1.047–1.142 | <0.001 | 1.127 | 1.065–1.193 | <0.001 | 1.266 | 1.097–1.460 | 0.001 |
| FBG | 1.039 | 1.003–1.076 | 0.035 | 1.050 | 1.004–1.100 | 0.035 | 1.122 | 0.993–1.267 | 0.065 |
| Hypertension | 1.049 | 1.011–1.088 | 0.010 | 1.064 | 1.015–1.115 | 0.010 | 1.151 | 1.018–1.301 | 0.025 |
| WC | 1.581 | 1.394–1.795 | <0.001 | 1.625 | 1.425–1.853 | <0.001 | 9.979 | 5.158–19.307 | <0.001 |
|
| |||||||||
| MetS | 1.191 | 1.118–1.269 | <0.001 | 1.250 | 1.153–1.356 | <0.001 | 1.710 | 1.384–2.113 | <0.001 |
| Triglycerides | 1.072 | 1.026–1.121 | 0.002 | 1.094 | 1.033–1.160 | 0.002 | 1.274 | 1.059–1.415 | 0.006 |
| HDL-c | 1.097 | 1.047–1.148 | <0.001 | 1.131 | 1.066–1.201 | <0.001 | 1.260 | 1.088–1.460 | 0.002 |
| FBG | 1.036 | 0.999–1.074 | 0.054 | 1.047 | 0.999–1.097 | 0.055 | 1.114 | 0.983–1.262 | 0.092 |
| Hypertension | 1.040 | 1.002–1.080 | 0.039 | 1.053 | 1.003–1.106 | 0.036 | 1.115 | 0.981–1.266 | 0.096 |
| WC | 1.610 | 1.404–1.846 | <0.001 | 1.639 | 1.427–1.883 | <0.001 | 10.798 | 5.362–21.744 | <0.001 |
Three logistic regression models were applied: model 1, adjusted for age; model 2, adjusted for age, race, marital status, driving experience in years, and education; and model 3, further adjusted for age, race, marital status, driving experience in years, education, smoking, alcohol and physical activity. BMI, Body Mass index; WC, Waist circumference; WHtR, waist-to-height Ratio; BRI, body roundness index; MetS, metabolic syndrome. HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; WC, waist circumference.
Figure 3ROC curve of the various combination of two anthropometric indices fir identifying the MetS.
Area under the curves (AUC) for the various combinations of two anthropometric indices for identifying MetS.
|
|
|
| ||
|---|---|---|---|---|
| BMI and BRI | 0.843 | <0.001 | 0.788 | 0.898 |
| BMI and WHtR | 0.839 | <0.001 | 0.783 | 0.895 |
| BRI and WHtR | 0.832 | <0.001 | 0.775 | 0.889 |
BMI, Body Mass index; WC, Waist circumference; WHtR, waist-to-height Ratio; BRI, body roundness index; MetS, metabolic syndrome. HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; WC, waist circumference.